Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2000
11/29/2000EP0896603B1 Polymer powders redispersible in aqueous solution
11/29/2000CN2407774Y Stype
11/29/2000CN1275084A Recombinant porcine adenovirus vector
11/29/2000CN1275082A Solid oral dosage form comprising combination of metformin and glibenclamide
11/29/2000CN1275081A Aqueous liquid preparations
11/29/2000CN1275079A Stabilized compositions containing benzimidzole-type compounds
11/29/2000CN1275076A Method of administering liposomal encapsulated taxane
11/29/2000CN1274751A Artificial culture of Jiuzhou caterpillar fungus and the application of its sporophore
11/29/2000CN1274605A Oral insulin granule and its preparation
11/29/2000CN1274596A Compound bee venom liniment and its preparation
11/29/2000CN1274589A Kidney warming and Yang strengthening capsule and its preparation
11/29/2000CN1274582A Oral cesporan with long effect
11/29/2000CN1274580A Stable delayed vitamin C preparation and its production process
11/29/2000CN1274579A Method for producing particle with hepatoflavin
11/29/2000CN1274578A Preparation of Azithromycin solution and semi-solid
11/29/2000CN1058899C Menalgia plaster
11/29/2000CN1058894C Compound cold-preventing nose drops and their preparation
11/29/2000CN1058885C Drug-stopping addiction-removing capsule
11/29/2000CN1058877C Aconite granular preparation and its preparation method
11/29/2000CN1058876C Huanghuafuyanling (oral) capsule containing goldenrod for treating gynaecology inflammation
11/29/2000CN1058872C Method of producing medicine for treatment of chronic osteomyelitis
11/29/2000CN1058870C Wenxianglu smedicinal liquid for curing cold
11/29/2000CN1058868C Long-effect and broad-spectrum antibiotic granules and making method of its products thereof
11/29/2000CN1058864C Method for producing microcapsule
11/28/2000US6153678 Comprising a poly(caprolactone), a poly(alkylene oxide), a poly(oxyethylenated fatty acid ester), or a poly(oxyethylenated fatty acid), or a poly(oxyethylene-co-oxypropylene); drug delivery
11/28/2000US6153644 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
11/28/2000US6153635 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
11/28/2000US6153623 Cisapride extended release
11/28/2000US6153610 For treating cancer tumors
11/28/2000US6153607 Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover)
11/28/2000US6153598 Acts as synthetic vector for achieving efficient transfection of associated nucleic acid into a cell; gene therapy
11/28/2000US6153582 Defined serumfree medical solution for ophthalmology
11/28/2000US6153228 Propolis extract
11/28/2000US6153227 Reducing the odor by soaking propolis in a hydrophilic solvent, e.g., methanol, to effect extraction followed by treating the liquid layer with an anion exchange resin; without attenuating the inherent biological activities
11/28/2000US6153225 Injectable formulations of nanoparticulate naproxen
11/28/2000US6153224 Carrier particles for use in dry powder inhalers
11/28/2000US6153223 Premixing a carrier and an aqueous solution of an acid and drying; mixing a stabilizing amount of the acidic carrier with a pharmaceutical agent unstable at a ph >3.5; forming a stabilizing microenvironment around the pharmaceutical agent
11/28/2000US6153222 A swellable film comprising a mixture of fillers, cleansers, cosmetics, or active substances, film formers, and softeners having portions of a highly absorbent hydrogel former which swells on contact with water; dentifrices
11/28/2000US6153221 Use of biogically active glass as a drug delivery system
11/28/2000US6153220 Taste-masked formulations
11/28/2000US6153219 Oral composition
11/28/2000US6153218 Biphasic capsule formulation
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/28/2000US6153216 Transdermal estradiol/progestogen agent patch and its production
11/28/2000US6153215 Between the medicament-containing layer and a release face is a barrier layer of a dispersion of a continuous hydrophobic phase and a discontinuous hydrophilic phase which is water soluble or water swelling; time-release; broad profiles
11/28/2000US6153213 A bolus for supplying vitamin e to a ruminant animal, comprising a material such as a silicate gel which swells by absorption of water, expanding to apply pressure to an elastic container, causing the nutrient to be expelled
11/28/2000US6153212 Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
11/28/2000US6153211 Mixing biologically active drug with a macromer, polymerizing the mixture to form particles, administering the particles for therapeutic treatment
11/28/2000US6153210 Use of locally delivered metal ions for treatment of periodontal disease
11/28/2000US6153207 Anti-cellulite pantyhose
11/28/2000US6153193 Compositions for targeting biological agents
11/28/2000US6153187 Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
11/28/2000US6153173 Propellant mixture for aerosol formulation
11/28/2000US6153129 Production scale method of forming microparticles
11/28/2000US6152897 Bi-compartment, one-dose syringe comprising a first chamber containing freeze dried mixture of growth hormone, mannitol and an amino acid and a second chamber containing an injectable aqueous reconstitution solution; storage stability
11/28/2000CA2309375A1 Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for steroid
11/28/2000CA2300452C Orally administrable solid ribavirin dosage forms and process for making them
11/28/2000CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/28/2000CA2208068C Medicated tissue paper product
11/28/2000CA2200795C Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
11/28/2000CA2182575C Oil-in-water emulsions
11/28/2000CA2085037C Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor compound
11/28/2000CA2046308C Radiolabeled colloid compositions, their use and process for their preparation
11/28/2000CA1341147C Sunscreen compositions
11/27/2000CA2309373A1 Novel topical formulations
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070043A1 Recombinant human mannan-binding lectin
11/23/2000WO2000069942A1 Stabilization and acoustic activation of polymeric micelles for drug delivery
11/23/2000WO2000069915A2 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
11/23/2000WO2000069894A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000WO2000069887A2 Rapid dehydration of proteins
11/23/2000WO2000069861A1 THIAZOLOPYRIMIDINES USEFUL AS TNFα INHIBITORS
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069520A2 Use of topical azathioprine to treat inflammatory bowel disorders
11/23/2000WO2000069515A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
11/23/2000WO2000069510A1 Energized trace elements
11/23/2000WO2000069470A2 Improved cellular uptake of bioactive agents
11/23/2000WO2000069469A1 Topical compositions for prostaglandin e1 delivery
11/23/2000WO2000069468A1 Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
11/23/2000WO2000069456A2 Adjuvant combination formulations
11/23/2000WO2000069449A2 Conditioned cell culture medium compositions and methods of use
11/23/2000WO2000069442A1 Methods of making and using n-desmethylzopiclone
11/23/2000WO2000069440A2 Nicotine delivery systems
11/23/2000WO2000069431A1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
11/23/2000WO2000069422A1 Patch
11/23/2000WO2000069421A2 Transdermal therapeutic system (tts) containing tolterodine
11/23/2000WO2000069420A1 Pulse-delivery oral compositions
11/23/2000WO2000069419A1 Controlled active substance release capsule
11/23/2000WO2000069418A1 Process for making cellulose ether capsules with organic acids
11/23/2000WO2000069417A1 Process for preparing pharmaceutical bulk material having uniform dissolution
11/23/2000WO2000069416A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives
11/23/2000WO2000069415A2 Melt granulation
11/23/2000WO2000069414A2 Granules containing a plant substance and method for producing the same
11/23/2000WO2000069413A1 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
11/23/2000WO2000069412A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
11/23/2000WO2000069411A1 Use of polymeric adsorbents in pharmaceutical dosage forms
11/23/2000WO2000069405A1 Method for treating acne or isolated pimples and adhesive patch therefor
11/23/2000WO2000069269A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium
11/23/2000WO2000069255A1 Anti-inflammatory therapy for inflammatory mediated infection
11/23/2000WO2000051572B1 Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
1 ... 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 ... 2991